Dr. Skapek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2301 Erwin Rd
Durham, NC 27705Phone+1 919-684-3401Fax+1 919-681-7950
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1991 - 1994
- San Antonio Uniformed Services Health Education ConsortiumResidency, Pediatrics, 1988 - 1991
- Duke University School of MedicineClass of 1988
Certifications & Licensure
- NC State Medical License 2024 - 2024
- TX State Medical License 2011 - 2024
- IL State Medical License 2007 - 2014
- TN State Medical License 1999 - 2007
- MA State Medical License 1991 - 1999
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2008 Aug 04
- A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response Start of enrollment: 2010 Jul 01
- A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 1 citationsGenomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer.Funan He, Abhik M Bandyopadhyay, Laura J Klesse, Anna Rogojina, Sang H Chun
Nature Communications. 2023-11-22 - 3 citationsComprehensive characterization of patient-derived xenograft models of pediatric leukemia.Anna Rogojina, Laura J Klesse, Erin Butler, Jiwoong Kim, He Zhang
Iscience. 2023-11-17 - 117 citationsChildren's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas.Douglas S. Hawkins, Sheri L. Spunt, Stephen X. Skapek
Pediatric Blood & Cancer. 2013-06-01
Press Mentions
- Children’s Health Appoints New Chief of Cardiology for the Heart CenterSeptember 13th, 2021
- UT Southwestern Develops System to Identify Genetic Anomalies Connected to CancerJuly 8th, 2018
- Groundbreaking Genetic Research Could Help Diagnose and Cure Cancer in ChildrenJuly 6th, 2018
- Join now to see all
Grant Support
- TGF 2-2 Controls P19ARF During Eye DevelopmentNational Eye Institute2012
- ARF Controls Vascular Regression During Eye DevelopmentNational Eye Institute2012
- TGF 2-2 Controls P19ARF During Eye DevelopmentNational Eye Institute2010–2011
- ARF Controls Vascular Regression During Eye DevelopmentNational Eye Institute2007–2011
- Translation Of Predictive Cancer Biomarkers Into Clinical PracticeNational Cancer Institute2009–2010
- ARF Controls Vascular Regression During Eye DevelopmentNational Eye Institute2003–2007
- Cell Cycle-Dependent Regulation Of MyogenesisEunice Kennedy Shriver National Institute Of Child Health &Human Development1999
- Cell Cycle-Dependent Regulation Of MyogenesisEunice Kennedy Shriver National Institute Of Child Health &Human Development1996–1998
- Cell Cycle Dependent Regulation Of MyogenesisEunice Kennedy Shriver National Institute Of Child Health &Human Development1995
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: